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Metallic nanoparticles
 
possess unique electrical, optical and biological performances that have 
attracted considerable attention due to their potential use in many applications, such as catalysis, drug 
delivery, nanodevice
 
fabrication, etc. Capped silver nanoparticles
 
(AgNPs) have many biomedical 
applications due to its excellent biocompatibility, antiviral and antibacterial properties. However, in the 
literature it has been reported that bare silver nanoparticles
 
can be toxic. This supports the idea that 
the toxicity is associated to the presence of bare metallic nanoparticle
 
surfaces, while particles 
protected by the organic layer are much more biocompatible and thereby less toxic. Poly (α, γ, L-
 
glutamic
 
acid) (PGA) is a hydrophilic, biodegradable, and naturally available biopolymer. Its biological 
properties such as nontoxicity, biocompatibility, and nonimmunogenicity
 
qualify it as an important 
biomaterial in drug delivery applications. In this study we used
 
PGA as organic layer for silver
 
 
nanoparticles.
Poly (α, γ,
 
L-glutamic acid) (PGA)
 
capped silver nanoparticles
 
were prepared by chemical reduction 
method with saccharide
 
(saccharose or glucose)
 
as reducing agent.
 
PGA was obtained from Guilin 
Peptide Technology Limited. Molecular weight of the PGA was 20000-40000
 
g/mol.
The synthesis procedure was carried out as follows (Figure 1): When sodium hydroxide (NaOH) is 
added, the precursor solution-AgNO3
 
turns into dark color of Ag2
 
O precipitate. The addition of a 
NH4
 
OH into the solution make solution clear. After that the disaccharide-
 
saccharose
 
or 
monosaccharide-glucose, as a reducing agent, was added into the mixture. The formation of silver 
nanoparticles
 
can be observed by a change in color since small nanoparticles
 
of silver are yellowish 
green. The addition of a small amount of poly(α, γ, L glutamic
 
acid) will prevent aggregation of the 
nanoparticles. A layer of absorbed glutamic
 
acid anions on the surface of the nanoparticles
 
keep the 
nanoparticles
 
separated.
The samples were characterized by Ultraviolet Spectroscopy (UV)
 
and Field Emision Scanning Electron Microscopy (FESEM)
Results
The UV spectroscopy has been used to verify the formation of 
silver nanoparticles without and with PGA in the solution. 
The UV measurements were performed on GBC, Cintra
 
101 UV-
 
VIS Spectrophotometer in the frequency interval of 300-600 nm.
UV-Vis
 
absorption results confirmed formation of silver 
nanoparticles
 
prepared in liquid by chemical reduction method 
(silver nitrate AgNO3
 
reduced by disaccharide-
 
saccharose
 
or 
reduced by monosaccharide-glucose). Silver nanoparticles
 
were 
capped
 
with poly (alpha, gama L-glytamic acid) by 
homogenization of colloidal silver and polymeric solution.
UV–Vis
 
spectra of nine
samples taken from 
the same reaction
between 30
 
and 40
 
min 
water solution 
of AgNO3
addition of 
NaOH precipitation of 
Ag2
 
O
disaccharide-
 
saccharose
 
or 
monosaccharide-
 
glucose
step 1 step 2 step 3 step 4 step 5
addition  of 
NH4
 
OH
homogenization 
with
 
poly (α,γ
 
L -
 
glutamic
 
acid)
To clarify the microstructure of the silver nanoparticles
 
FESEM observation has been 
carried out.
The FESEM measurements were performed on a SUPRA 35 VP Carl Zeiss
 
field-emission 
scanning electron microscope. The samples were prepared by re-dispersing in ethanol by 
means of an ultrasonic bath and filtering the dispersions using polycarbonate membranes. 
Carbon was used to prevent charging.
From FESEM images it can be noted that capped silver particles obtained with 
disaccharide-
 
saccharose
 
are very uniform and with sizes on nanometer scale. Particles 
have spherical shapes and surfaces without cracks or pores. Size
 
distribution of all 
nanoparticles
 
was unimodal
 
and with sizes of about
 
10 nm.
Conclusion
Poly (α, γ, L-glutamic
 
acid) (PGA) is an 
anionic biocompatible macromolecule 
that has been used for drug delivery in a 
variety of clinical trials.
 
In this study
 
PGA
 
was used as organic layer for silver 
nanoparticles
 
obtained with two different 
reducing agents (saccharose
 
and 
glucose).
 
The capping agent (PGA) was 
chosen to make the silver nanoparticle
 
more biocompatibile
 
and to protect 
nanoparticles
 
from agglomerating in the 
medium. The obtained silver 
nanoparticles
 
are very unform and with  
sizes of about 10
 
nm. The obtained silver 
nanoparticles
 
were highly stable and 
water soluble.
UV spectra of silver nanoparticles without PGA and capped silver
 
nanoparticles with PGA
(glucose as reducing agent)
UV spectra of silver nanoparticles without PGA and capped 
silver nanoparticles with PGA
(saccharose as reducing agent)
The absorption spectra of the
 
silver colloids and
 
PGA-capped 
silver colloids are presented. In the UV-Vis
 
absorption spectra of 
PGA capped silver nanoparticles obtained with saccharose as 
reducing agent narrow surface plasmon absorption peak at 410
 
nm were observed.  This confirms the nanocrystalline character 
of the particles and the low degree of their polydispersity , 
which is in the ageement with our FESEM observations. 
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